Steminent Biotherapeutics Inc. (7729.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan · ISIN TW0007729006
Steminent Biotherapeutics Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 0.00 TWD | – |
| Gross profit | -16.43 m TWD | – |
| Operating income | -162.30 m TWD | -173.66 m TWD |
| EBIT | -156.69 m TWD | -171.99 m TWD |
| Net income | -158.75 m TWD | -174.04 m TWD |
| Diluted EPS – continuing operations | -2.84 TWD | -2.57 TWD |
Full history since 2020, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Steminent Biotherapeutics Inc.
Steminent Biotherapeutics Inc. operates as a biopharmaceutical company in Taiwan and the United States. It provides Stemchymal, a cell therapy product for the treatment of neurodegenerative diseases, including spinocerebellar ataxia and huntington's disease; tissue regeneration, such as osteoarthritis; and acute syndromes consisting acute respiratory distress syndrome, liver failure, and ischemic stoke. The company was founded in 2009 and is based in Taipei, Taiwan.
More stocks
- Tatton Asset Management PLC (TAM.L)
- PCL Technologies Inc (4977.TW)
- Zhejiang Xiantong Rubber&Plastic Co Ltd (603239.SS)
- DXN HOLDINGS BHD. (5318.KL)
- LIGHTPATH TECHNOLOGIES INC (LPTH)
- VAALCO ENERGY INC /DE/ (EGY)
- Zhejiang Jindao Technology Co. Ltd. (301279.SZ)
- Stark Technology Inc (2480.TW)
- Temple & Webster Group Ltd (TPW.AX)
- Lumina Metals Corp. (LMU.WA)
- Echo Investment SA (ECH.WA)
- Goldcard High-Tech Co Ltd (300349.SZ)
Not investment advice. All data without warranty, price as of 10.11.2026. Details in the risk notice.